Jump Financial, LLC Curis Inc Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.71 - $2.43 $63,899 - $218,697	-89,999 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.31 - $5.13 $45,047 - $100,040	-19,501 Reduced 17.81%	89,999 $215,000
Q4 2021 Feb 10, 2022	BUY	$4.45 - $8.09 $431,040 - $783,621	96,863 Added 766.5%	109,500 $521,000
Q3 2021 Nov 12, 2021	BUY	$6.94 - $8.85 $87,700 - $111,837	12,637 New	12,637 $99,000
Q2 2021 Aug 13, 2021	SELL	$7.45 - $16.27 $512,560 - $1.12 Million	-68,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $604,064 - $880,640	68,800 New	68,800 $779,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.